Reddit Posts
PRESS RELEASE: Citius Pharmaceuticals Reaches 92 Event Milestone in Mino-Lok Phase 3 Trial
It’s time for CLVS again - Company is about to submit supplemental information to FDA and European Commission for Rucaparib
ITT: we list the things we could have done with the money that we lost to Ryan Cohen’s scheming
Grandpa Biden rfibally did something right and refunded $20k of my BS student loans from ITT TECH. where should I invest it??
NeuroMetrix Inc's price actual 25,30 +153,00% FDA approval
Nasdaq:TRCH is where I’ve made the most, missing the rocket that is AMC and GME. ITT Torchlight
My Watchlist For 5/28/2021 -- Told You $X Was A Snack
Five Top Contenders Competing For Multi-Billion-Dollar PFAS Removal Race - One Appears To Have Formidable Competitive Advantages
Mentions
**ITT: obvious astroturf bots and obvious advertisement for a scam trying to execute the classic pig slaughter scam**
the most ringing endorsement I've seen of him ITT
ITT: people taking the obvious bait
ITT: A lot of people that can't code and have never used LLM's in their workflow
Someone buys a promise for 1 IRR otc for $0.0008. ITT: The next big arbitrage play!!!!!!!1111
ITT: dudes in absolute disbelief that 25+ P/E stocks have the audacity to fall a bit
AFL, ALL, ITT. All over 10 years. They’ve been good. AFL has been stagnant for about a year though.
ITT: nobody who was actually invested in 1929 🥱
ITT: people desperate to be outraged by a bill they don’t understand in a country that they don’t understand.
Retatrutide does not destroy anything. It has 18% DC rate due to side effects and likely > 25% Total DC rate. Tough at higher doses with 20% dysesthasia and I know risk is tachyarrythmia ( Lilly didn’t disclose at triumph 4 top line ) When comparing $LLY Triumph 4 retatrutide wt loss and the difference from efficacy estimate (EE) to treatment estimand (TE) vs phase 2 that was published in NEJM 2023 ( 24% EE and 20% TE at 48 Wks , below ) you see exactly same trend of wt loss drop when looking at ITT roughly same wt loss of 20% at 48 wks that likely seen in Triumph 4 ( we don’t have curves yet, just my guess ). Just clear reproducibility of all data from phase 2 to 3 and will see same outcome in all retatrutide phase 3 trials that will be reported in 2026 ( don’t let Lilly fool u with statements and wait for more trials ) Same thing was seen when I compared $LLy orforglipron phase 2 to phase 3 and adjusted for escalation.
Minimizing cost of capital. Everyone ITT likes to point to a bubble or corporate greed but its really as simple as that. If i could borrow money at below market market rate for decades, I would.
This is literally all he said about China and gold... > They’re having to tighten margin requirements. So gold looks to me kind of like a classical, speculative blowoff. That's perfectly likely. Gold became speculative, and the Chinese sold high. That's just what good trading looks like at the national scale. People ITT having a meltdown at even the mention of China doing harmful things to the US economy are being hyperbolic and ridiculous. China will always hurt the US if they can do it without starting a war. It's in their best interests for the US to be weakened, and they've demonstrated consistently that they will always help weaken the US. But, none of that matters because the US is too inept now to do much about it.
ITT: smart people's exit liquidity
ITT - Bulls freaking out about losing the monopoly $$$ they gained in the past 3 years from a monopoly market.
ITT - people saying "TwO pERceNT iS nOt a SeLlOfF" while neglecting that the undercurrent that propped this market up (tech) is falling apart and will definitely pull the broader market down significantly.
Pretty cool to see ITT hit ATH this morning
Agree with ASTS but there are profitable companies like OSIS, GHM, MOG.A, ITT are a few example of profitable companies seeing growth in the space sector.
ITT: people who don’t understand inflation and casual chipotle goers. I’ve been eating there since 2006/07 and portion sizing has always been a hit or miss. It’s simply left up to the employee making it. Since door dash’s takeover, that’s about the only time you can get skimped consistently.
ITT: troglodytes butthurt from being banned on a subreddit who will miss out on the most obvious earnings reversal of all time.
ITT: people that money shorting TSLA lmao
ITT people who know nothing about microstrategy’s finances and obligations
ITT: Folks who have apparently never bought high over a period of...a couple days?
Okay, I just read every comment ITT, and there is no reason given at all for any reasonable amount of revenue growth, except that they're going to try to charge users for data retention. Imo, that will only annoy users, and most will leave, even if the subscription is pennies. I bet the vast majority of users would leave the platform before giving them a credit card to charge.
ITT people who don’t even invest have knee jerk emotional response, and perhaps even find out Tesla isn’t just a car company, and that’s just the tip of the iceberg. Look at Mitsubishi.
ITT... People buying the dip while publicly taking PLTR
ITT people say Reddit sucks but continue to use it daily 😂🤣🫡
ITT I see the 1st stage of grief in some: Denial.
ITT: people salty who didn’t buy since IPO
ITT: Europoors bitching about how America sucks like can yall shut up already
100 years of red scare propaganda goes brrr ITT, it's almost amazing. I mean in mainstream US discourse you use the terms "liberal" and "left" synonymously. That alone is plein insanity, from a basic pol itical analysis POV
ITT: retard who believes this administration
The sad part is that the ones ITT are some of the smarter Americans. Tells you something
Unsurprisingly, ITT: Reddit now supports the banks.
Great company, don’t own. Solid run this year so far. There’s some other names in the space sector that are profitable and a bit under the radar. GHM, ITT, FEIM, CW, ATI, CRS, BELFB/BELFA, LDOS, AMTM, MOG.A are few other names to play space/defense with companies that are profitable.
DIOD been a real stinker. STM too. But part of that is the story of autos and chips. When people talk about semi's, they lump everything together, but there different type of chips. Anything auto related basically has sucked for a while. I don't think the market has bottomed for that yet. Same with some of the analog names. I don't always hit home runs. However, I do feel like I have a pretty good track record. Here's another one: [https://www.reddit.com/r/stocks/comments/18ya1l6/comment/kgafpop/?utm\_source=share&utm\_medium=web3x&utm\_name=web3xcss&utm\_term=1&utm\_content=share\_button](https://www.reddit.com/r/stocks/comments/18ya1l6/comment/kgafpop/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) Names mentioned in there are CECO, CWCO, CW, MOD, ITT, AIT, POWL, PSTG Since that post: CWCO +14% CECO +242% CW +202% MOD +120% ITT +60% AIT +72% POWL +400% PSTG +109% Not too bad from 2 years lol.
ITT: a bunch of perpetually online redditors trying to cope with a market making new ATHs by saying why this is bad
ITT: aggressively divorced men licking boots. Godspeed Powell.
That’s the smartest guy ITT tbh
Here is a list of names that have space exposure that are generating profits and should benefit from any space boom: ITT, GHM, FEIM, OSIS, MOG.A, LDOS, AMTM, CRS, ATI, CW I post more in the daily and have been posting about these names for years, including RKLB.
ITT people who wanted ths for the past 5 years but wont acknowledge this as good news because trump. Add it to the list of things the left asked for but when trump does it its a bad thing
OSIS, GHM, ITT, FEIM, ATI, BELFB, MOG.A I own all these, haven't look at the current fundamentals, but basically all these are actually generating FCF.
Holy shit so many people ITT are holding on to WAY TOO MUCH cash.
ITT: a guy trying to bill himself as a Wall Street insider seems to confuse /r/investing with /r/wallstreetbets in a haughty tone
ITT: gaslighting shills defending USA's imperialism regime once again because we got "the bad guy" gj boys
Started looking into $ITT. Wouldn't consider it undervalued, but rather fairly valued at TTM PE of 30, FWD PE of 24 at a PEG of 1.93. As of last earnings debt-equity is 0.41 and current ratio is 1.52 which I would consider a strong position on the balance sheet. Acquisition of SPX Flow will expand its products from motion absorption components (brake pads, shock absorbers, etc.) to fluid control (centrifugal and positive displacement pumps).
It's amusing that you assume from complete ignorance what I know, what I don't, and what I was even referring to, which you got entirely wrong. The Bureau of Economic Analysis is also under the thumb of the administration. The October shutdown affected data analysis that was ongoing, which obviously includes data from August and September. Table A is absolutely concerning, but that will be in the next blatantly manipulated report, and again, not what anyone here was talking about. We are talking about how all of this data diverges significantly from literally all other data. Everything that has matched relatively consistently for decades now all of a sudden doesn't match at all. Hundreds of people ITT are pointing it out, and economists throughout the world are throwing alarms.
Looks like you're feeling good about these ones, too: > CW, ESE, MOG.A, kind of OSIS, GMH, and ITT. I have to do some homework, it seems. I'll admit that I don't know any of these aside from GHM.
ITT: Redditors who don't know basic economics
ITT: Reddit smarter than the trillions of dollars hedge funds and algos base their trading on Reddit of course knows the real truth. The math Olympian PhD's who work at Jane Street and Citadel don't know anything and are being fooled.
But the brain trust ITT will tell you SpaceX has no moat.
ITT: The economy is permanently different now, so the old warning signs don't matter anymore. Same thing people said before every crash.
New ITT acquisition > SPX FLOW provides highly engineered equipment and process technologies for industrial, health, and nutrition sectors. “The acquisition of SPX FLOW adds critical equipment and adjacent flow and process technologies that extend ITT’s capabilities to address complex customer challenges across growing end markets with secular trends, including industrial, chemical, energy, mining, nutrition and health and personal care,” ITT (ITT) said.
I specified that mortgages are different, but they look at more than salaries. Lenders also look at debt-to-income, credit history, employment history, trends around home values in the neighborhood, insurance costs, etc. You could have a good salary, but if you just got your first job, recently got a big raise or work in an unstable industry, the approval amount will reflect that. Our UBS portfolio is worth over twice the value of our home, household income is over $1M, we have near-perfect credit and we borrowed through UBS, but we still only got less than a 1% break on the interest rate. This is all to agree with you that mortgages are *easier* to get than loans for investments, because the collateral is the thing you are buying, but lenders still don't take them lightly (post-2008, anyway). Therefore, I would be shocked if you could borrow millions to invest with unless you have a very expensive home and/or significant existing wealth. Not that you have claimed otherwise, but some ITT seem to assume that anyone off the street could make a similar play.
lotta doubters ITT guess I better buy more
ITT TECH Graduate
ITT: OP has no clue what people are thinking 😭
ITT: An user that can't comprehend that more than one person comments in a subreddit
ITT: bers who thought mm would actually pay out 100,000 0dte puts
ITT: clueless person argued about thing they do not understand
Bers selling out bulls taking profits SQUEEZE ITT
ITT: a bunch of midwits show that they have done 0 research and are trying to short a stock at the bottom of a move.
ITT everybody thinks you're cooked so this may work out for you
ITT: The gang discover credit call spreads.
ITT: “everyone in the AI industry is an idiot, I’m the smart one in the room.”
ITT ppl who need to look into: asymmetry/convexity. It's OK to be wrong *all the time* if the goal's explosive/non-linear upside.
ITT: everyone ignoring the labor market
Yeah people ITT dont know that while depreciation is meant to represent the useful life its usually very conservative of an estimate.
Lotta bears ITT. This feels like it's setting up for a very bullish December. Gonna be interesting how the market reacts. If money supply comes back, we can see 700 by eoy.
Lotta folks ITT weren't alive/of age/investors in 2008 and it shows.
ITT: Bears who have been calling for a crash since SPY 500 acting like geniuses because SPY is at 666
Yeah, I post about these type of companies here a lot. I find them really interesting. Like PH is great, but I think there is better value/better investments in the space, however PH is still solid. I've moved a lot of position into aerospace the last 6months or so, since it's just been killing it and it's a great way to get out of tech. Like I'm better heavy in data center and electrification, but I've been there before the LLM's and explosive growth. So wanted to get some exposure out of those sectors and aerospace is rad. $CW is another really cool name, but it's more energy/naval/aerospace play. I love $OSIS which gets you some aerospace and just general defense. $ESE is kind of like $CW, but more focused on naval. $MLI is extremely boring, does like copper pipping, but is a set and forget type of investment. $APH is boring connectors company, but this more data center exposure, but still have business in things like aerospace. $ITT does like pump values and what not, with some aerospace. $HWM is another name that does like fasteners for planes. $MOG.A is another boring company that does like sensors for aerospace.
ITT ppl who should brush up on ideas of: asymmetry/convexity. It's OK to be wrong *all the time* when we're after explosive/non-linear upside.
ITT: People finding it hard to understand exponential growth. The demand for compute is off the charts, and AI adoption has only just begun. It’s not that difficult to imagine an 8.5T market cap for NVDA, given that AI infrastructure spending will continue growing around the world. It’s not a bubble if it’s supported by earnings growth.
ITT: lots of butthurt losers who missed every single chance to get on the train. It's okay, I'm sure there'll be many more chances to miss for you guys!
ITT: 99% politics 1% stock specific discussion of the investment itself (u/Warren_Puff-it made a good post, u/stinker_pinky made a good point)
For sure, valuation looks solid, even after the big jump. Share anything you find if you dig into over the weekend. If you haven't looked into them as well, ITT is a solid boring company. Good growth, good ROIC. Just a set and forget type of investment.
I've seen the name before while screening, but never really looked too much into them. Valuation is pretty solid! They kind of seem like ITT a bit, which is a company I've been long on for a while. Looking at their quarter presentation: [https://s204.q4cdn.com/928084406/files/doc\_financials/2025/q3/FLS-Q3-2025-Earnings-Presentation.pdf](https://s204.q4cdn.com/928084406/files/doc_financials/2025/q3/FLS-Q3-2025-Earnings-Presentation.pdf) Looks to be kind of an under the radar nuclear name.
Altimmune ($ALT) — Near-term catalysts in MASH; 48-week readout and FDA meeting on deck Altimmune’s dual GLP-1/glucagon agonist pemvidutide has positive 24-week Phase 2b data in MASH with weight loss and strong NIT signals. Near-term catalysts include: (1) Q3 results + business update on 6 Nov 2025, (2) AASLD late-breaking oral/poster the same week, and (3) 48-week IMPACT data in Q4 2025, followed by an End-of-Phase-2 (EOP2) FDA meeting targeted for Q4 2025. Cash was $183.1m (30 Jun 2025). Watch short-interest dynamics and the Phase 3 path in MASH. Investment thesis (biotech-focused, medium risk) Clinical signal: At 24 weeks, pemvidutide met the primary endpoint (MASH resolution without fibrosis worsening) with up to 59.1% response in ITT analysis, alongside meaningful weight loss and improvements on NITs (e.g., ELF, VCTE, cT1). These markers support anti-inflammatory and anti-fibrotic activity pending biopsy-based confirmation at 48 weeks. What’s different: Company secured late-breaking slots at AASLD 2025 (oral + poster) for 24-week data, a credibility signal in liver circles, and guides to 48-week IMPACT data in Q4 2025 (weight, NITs, safety). Execution adds up: Altimmune scheduled Q3 results and business update on 6 Nov 2025; management recently strengthened clinical leadership by appointing Christophe Arbet-Engels, M.D., PhD as CMO to steer Phase 3 in MASH. Near-term catalysts (dated) 6 Nov 2025 (Thu): Q3 results & business update call (watch for Phase 3 colour, 48-week timing, cash runway commentary). 7–11 Nov 2025: AASLD The Liver Meeting late-breaking oral + poster on 24-week IMPACT data; expect slides/posters on the IR site. Q4 2025: 48-week IMPACT readout (weight loss trajectory, NITs, safety; biopsy subset/AI fibrosis analyses may be discussed). Company also targets EOP2 FDA meeting in Q4 2025 to align Phase 3. Balance sheet & ownership watch-outs Cash: $183.1m as of 30 June 2025; net loss $22.1m for Q2. Provides a cushion into 2026, but Phase 3 will be capital-intensive—monitor financing overhang. Short interest: As of 15 Oct 2025, reported short interest around 21.5m shares (down vs end-Sept). Any data surprise can move borrow/price quickly. Pipeline context (beyond MASH) Obesity: EOP2 meeting for obesity completed previously; programme remains a strategic option post-MASH clarity. Adjacencies (liver/behavioural): RECLAIM (AUD) and RESTORE (ALD) Phase 2 trials initiated in 2025 - optionality if MASH succeeds. Key risks Biopsy-level uncertainty: 24-week signals are strong, but regulators care about biopsy endpoints and longer-term safety; 48-week data are the inflection. Funding/dilution: Advancing to MASH Phase 3 likely requires more capital. Watch the Q3 call and subsequent filings. Competitive landscape: GLP-1s and emerging MASH agents are crowded fields; differentiation on efficacy/tolerability, fibrosis impact, and combo potential will matter (AASLD discussion will help).
ITT: angsty chadlets and autism (me)
Congrats to the new father ITT that sold his puts for $100K profit at the bottom of that candle lol
$ITT Q3 Non-GAAP EPS of $1.78 beats by $0.11. Revenue of $1B (+13.0% Y/Y) beats by $25.74M. 18.0% operating margin (18.5% adjusted) driven by productivity, higher volumes and pricing
Perhaps one of the more nuanced comments ITT. Thank you.
ITT: people who still don't understand in 2025 that social media is about attention and only about attention.
ITT: Whiners with 10k in their account complaining about a 200k shares yolo not being options. How ya think he got to 200k? Options on BYND? FUcking doubt it
ITT: why apple is amazing in every way, please validate my position
ITT: people who don’t even know how to use TradingView and think this is somehow a misleading narrative. As if gold hasn’t significantly outperformed the SPX for the past 25 years.
ITT: a bunch of le redditors thinks they're smarter than Martin fucking Shkreli 🤣😂🤣😂
ITT: people who would rather lose thousands of dollars again and again instead of reading like 10 paragraphs on how options work.
ITT: bols think that was the dump
ITT: Bol jerking each other off while making eye contact.
The delusional CCP shilling ITT is absurd. I loathe Trump, but pretending Xi won by threatening rare earth blocks is just plain laughable. Trump could completely decouple from China tomorrow and spin it as national security, and his base would gargle it with his balls. If he said the US is going to war with China, they'd do it. Also, there's plenty of rare earths in the US and from other countries. If China wants to lose the US market for them, best of luck with that short-term strategy.
ITT: Bol losing their goddamned minds. > #LMAO 🤌